دورية أكاديمية

1051P Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease

التفاصيل البيبلوغرافية
العنوان: 1051P Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease
المؤلفون: Nikiforow, S., Baiocchi, R., Nasta, S., Weng, W., Loeb, D., Mahadeo, K.M., Whangbo, J., Phuong, P., Navarro, W., Gamelin, L., Sun, Y., Guzman-Becerra, N., Prockop, S.
المصدر: In Annals of Oncology September 2020 31 Supplement 4:S719-S719
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2020.08.1171